Uflex is currently trading at Rs. 169.90, up by 3.20 points or 1.92 % from its previous closing of Rs. 166.70 on the BSE.
The scrip opened at Rs. 168.40 and has touched a high and low of Rs. 172.00 and Rs. 167.00 respectively. So far 126174 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 194.50 on 10-Aug-2015 and a 52 week low of Rs. 110.00 on 27-Mar-2015.
Last one week high and low of the scrip stood at Rs. 170.90 and Rs. 155.40 respectively. The current market cap of the company is Rs. 1220.37 crore.
The promoters holding in the company stood at 44.02 % while Institutions and Non-Institutions held 6.48 % and 41.94 % respectively.
Uflex is in process of setting up 'Aseptic Packaging Plant' at Sanand in Gujarat with a Capex of Rs 580 crore in the first phase. This step has been taken in sync with Central Government's flagship scheme 'Make in India'.
The project is proposed to be commissioned and go operational by April 2017 and will employ around 250 people in the first phase. Completion of all the phases of the project will require a total investment of about Rs 1500 crore and will provide employment to around 3000 people. 90% of the output from this factory will cater to the domestic demand. Uflex has State-of-the-art manufacturing facilities at Noida, Jammu and Malanpur.
Uflex is engaged in production of Polyester chips, BOPET and BOPP films, printing and Coating Inks, facilities for Holography, Metalization and PVDC coating, making Gravure Printing Cylinders, Gravure Printing, Lamination and Pouch formation.
| Company Name | CMP |
|---|---|
| Uflex | 406.10 |
| EPL | 233.25 |
| AGI Greenpac | 585.45 |
| Huhtamaki India | 190.40 |
| TCPL Packaging | 2647.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: